Vivek Walimbe, Ph.D., former VP for Baxter Healthcare, to lead development of intracoronary imaging product and expand portfolio Farzad Parsaie, with three decades of med device leadership, to oversee Quality and Regulatory Affairs BEDFORD, Mass.–(BUSINESS WIRE)–SpectraWAVE, Inc., a pre-commercial medical imaging company focused on optical and computational insights for the […]
Other News
Rivus Pharmaceuticals Announces Positive Results from Phase 1 Trial of Lead Candidate HU6, Demonstrating Safety, Efficacy in Key Targets for Multiple Cardio-Metabolic Diseases
HU6 was well tolerated and increased resting energy expenditure Dose dependent weight loss and an improvement in metabolic parameters were also observed, despite the study not being powered to demonstrate them Enrollment for a Phase 2a Metabolic Trial of HU6 has completed with topline data expected in Q1 2022 HU6 […]
Newark Beth Israel Medical Center Names New Chief of Advanced Heart Failure Treatment and Transplant
David Seth Feldman, MD, PhD, FACC, FAHA, named new Section Chief of Advanced Heart Failure Treatment and Transplantation NEWARK, N.J., Nov. 1, 2021 /PRNewswire/ — Newark Beth Israel Medical Center, an RWJBarnabas Health facility, has named David Seth Feldman, MD, PhD, FACC, FAHA, the new Section Chief of Advanced Heart Failure Treatment and Transplantation. […]
IMPULSE DYNAMICS ANNOUNCES FIRST OPTIMIZER IMPLANT IN CHINA
Breakthrough CCM Therapy Now Being Implemented in China MARLTON, N.J., Nov. 01, 2021 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure, today announced the first implantation of a patient in China with its innovative Optimizer system delivering CCM […]
BioSig Increases Case Volume Estimates
The Company reports increased adoption and commercial activity of its signal processing technology for arrhythmia care Westport, CT, Nov. 01, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover […]
SomaLogic announces strategic collaboration with University Hospitals Cleveland Medical Center to treat diabetic patients at high risk of cardiovascular disease
BOULDER, Colo., Nov. 01, 2021 (GLOBE NEWSWIRE) — SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced a strategic collaboration with one of the nation’s leading academic medical centers, University Hospitals Cleveland Medical Center, where they will evaluate the impact of the company’s SomaSignal™ tests on the medical […]
ReValve Solutions, Inc. Announces Successful First Human Use of the Transeptal Mitral Valve Replacement
BAINBRIDGE ISLAND, Wash.–(BUSINESS WIRE)–ReValve Solutions, Inc., an innovator in the field of transcatheter structural heart replacement and repair, announced today it has successfully completed the first human use of its transcatheter, Palmetto System for mitral valve replacement. The patient was successfully treated who suffered from severe mitral valve regurgitation and […]
Masimo Launches Dual SET® Pulse Oximetry
NEUCHATEL, Switzerland–(BUSINESS WIRE)–Masimo (NASDAQ: MASI) today announced Dual SET® Pulse Oximetry for Root®, a highly versatile patient monitoring and connectivity hub. The first application of Dual SET® Oximetry is a significant advancement to Masimo SET®-guided critical congenital heart disease (CCHD) screening, with the CE marking and European launch of the Masimo SET® MOC-9® module and […]
HeartFlow Analysis is First AI-Enabled Technology to be Recognized by the American College of Cardiology and American Heart Association Guidelines as an Important Tool in Diagnosing and Treating Heart Disease
Chest Pain Guidelines also elevate coronary CT as the only first-line test for many patients REDWOOD CITY, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) — HeartFlow, Inc., the leader in revolutionizing precision heart care, today welcomed new clinical practice guidelines from the American College of Cardiology (ACC) and American Heart Association (AHA) that recognized […]
Cytokinetics Announces Preclinical Data Relating to CK-3828136 Presented at the 2021 Medicinal Chemistry Gordon Research Conference
SOUTH SAN FRANCISCO, Calif., Oct. 29, 2021 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that preclinical data relating to the discovery and optimization of CK-3828136 (CK-136) were presented at the 2021 Medicinal Chemistry Gordon Research Conference in West Dover, VT. CK-136 is a novel, selective cardiac troponin activator […]
